Welcome to Novo Nordisk Science Hub

Are you a healthcare professional?

EASD 2026 28 September - 2 October 2026

Efficacy and hypoglycaemia outcomes with once-weekly IcoSema vs glargine U100 in T2D by baseline BMI: COMBINE 4

Authors :

Linong Ji1; Raluca Maltesen2; Laura Pletsch-Borba3; Cathrine Scavenius3; Daisuke Yabe4; Viswanathan Mohan5

Affiliations
View Details Hide Details
{{ getPageNum(PDFPage) }}
Download the poster (.pdf)
Keywords
Diabetes
Congress short oral presentation
Insulin
IcoSema (Icodec Semaglutide)
Clinical